1 / 6

Opdyta 40mg injection online (Nivolumab)| Apple pharmaceuticals

Nivolumab is a generic form of brand name Opdyta 40mg which is a targeted therapy drug presently used to cure from melanoma, non-small cell lung cancer or kidney (renal cell) cancer , it belongs to a group of cancer drugs known as monoclonal antibodies, it is also known as an immune checkpoint inhibitor @ Apple Pharmaceuticals

RobbieRoyce
Download Presentation

Opdyta 40mg injection online (Nivolumab)| Apple pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. APPLEPHARMACEUTICALS We will not dispense any prescription medication without a valid prescription from a licensed physician.

  2. NIVOLUMAB Opdyta 40mg

  3. DESCRIPTION • INDICATION • Opdyta 40mg is indicated for the treatment of patients having conditions like : • • Melanoma which has spread or can’t be removed with surgery • • Non-Small Cell Lung Cancer which has spread or come back after chemotherapy • • Kidney (Renal Cell) Cancer which has come back after chemotherapy. Nivolumab is a generic form of brand name Opdyta 40mg which is a targeted therapy drug presently used to cure from melanoma, non-small cell lung cancer or kidney (renal cell) cancer. Opdyta 40mg belongs to a group of cancer drugs known as monoclonal antibodies.

  4. MECHANISM • DOSAGE • As single agent is either 240mg every 2 weeks or 480mg every 4 weeks given as IV infusion over 30 minutes until disease progression or unacceptable toxicity • With ipilimumab. The recommended dose of Opdyta is 1mg/kg administrated as an intravenous infusion over 30 minutes, followed by ipilimumab 3mg/kg given as IV over 90 minutes on the same day. Duration 3 weeks of max 4 doses, after completing combination dose continue the single agent treatment Opdyta stops the molecule activity called PD-1, and it is a protein which inhibits T cells from identifying and attacking inflamed tissues and cancer cells. PD-1 can trick the immune system into overlooking melanoma cells as normal cells. Opdyta triggers your immune system’s reacting to melanoma by inhibiting the PD-1 protein on T cells. The drug activates T cells so which they can attack melanoma cells anywhere in your body.

  5. PREGNANCY & LACTATION • The effects of Opdyta 40mg are expected to be greater during the second and third trimesters of pregnancy. There are no available human data informing the drug-associated risk. Advise pregnant women of the potential risk to a foetus. • STORAGE • Store at under refrigeration at 2°C to 8°C. • MISSED DOSE • If you missed a dose take it as soon as possible, if time reach for next dose, then skip missed dose and continue regular schedule. Avoid taking two doses at a time. Avoid taking missed dose within 12hrs of the next dose.

  6. CALL CONTACT US • +91-9987711567 MAIL VISIT US • applepharmaceutical@gmail.com • http://anti-cancer-drugs.com/ ADDRESS Apartment No.304 A Wing, Shiva Shakthi chs ltd, JP Road, Near Apna Bazar,Andheri(West),Mumbai - 400058.

More Related